Lupus nephritis (LN) is common in people with systemic lupus erythematosus (SLE) and advances, almost invariably, to end-stage renal disease (ESRD). In this issue of the JCI, Abraham, Durkee, et al. presented a large-scale immune cell landscape of kidney biopsies from patients with LN by combining multiplexed confocal microscopy imaging with customized computer vision and quantification. The presence of diverse CD4– T cells in small neighborhoods, but not of B cells or CD4+ T cells in large neighborhoods, is linked to the development of ESRD. Unexpectedly, B cells in the kidney heralded a good prognosis. The precise location of different types of immune cells allows inference on possible interactions between different immune cells and also between immune and kidney-resident cells. The data have important implications on the development of prognostic tools and effective targeted therapies in patients with LN.
Hao Li, Maria G. Tsokos, George C. Tsokos
Title and authors | Publication | Year |
---|---|---|
Lupus Nephritis: Immune Cells and the Kidney Microenvironment
Chernova I |
Kidney360 | 2024 |
Journal Club: Anti‐CD19 Chimeric Antigen Receptor T Cell Therapy for Refractory Systemic Lupus Erythematosus
Boulougoura A, Gendelman H, Surmachevska N, Kyttaris VC |
2023 | |
The immunoregulatory roles of non-haematopoietic cells in the kidney.
Tsokos GC, Boulougoura A, Kasinath V, Endo Y, Abdi R, Li H |
Nature reviews. Nephrology | 2023 |